- This event has passed.
Eye Injuries in the Civil War with Mark Breazzano, MD
September 10 @ 1:00 pm - 2:00 pm EDT| FREE
Hear an ophthalmologist’s thoughts on how Civil War surgeons dealt with eye injuries
Join us on Friday, September 10 at 1:00 PM on YouTube for a virtual program hosted by the National Museum of Civil War Medicine. You can tune in live by visiting youtube.com/user/nmcwm at the scheduled time.
Education Coordinator John Lustrea will talk with Mark Breazzano, M.D., Assistant Professor of Ophthalmology at Johns Hopkins University, about eye injuries in the Civil War. The Medical and Surgical History of the War of the Rebellion contains several case histories of soldiers wounded in the head area. Dr. Breazzano will analyze the treatment administered during the Civil War and compare it with how those injuries would be treated today.
Mark Breazzano, M.D., is a retina specialist and experienced surgeon seeing patients at the Wilmer Eye Institute’s locations in Frederick and Baltimore, Maryland. He specializes in the diagnosis and treatment of medical and surgical vitreoretinal diseases including macular degeneration, diabetic retinopathy, retinal detachment, epiretinal membranes, macular holes and more. Dr. Breazzano is an award-winning researcher and surgeon who holds a patent and has authored more than 80 publications including peer-reviewed papers, book chapters and abstracts that span a diverse selection of vitreoretinal diseases. His research has been featured in WebMD, Newsday, Medscape, American Council on Science and Health, and American Academy of Ophthalmology’s EyeNet Magazine. His research is focused on accurate determination of endophthalmitis in the setting of Candida bloodstream infections and optimizing medical and surgical management for blinding diseases.
Like these programs? Consider supporting our efforts by becoming a member or donating to the Museum! Your efforts ensure that we can continue sharing the story of Civil War medicine in this crucial time. In history, we can find hope amid our struggle against COVID-19.